This grant, offered by the National Institutes of Health’s Cooperative Research Centers, is specifically designed to advance vaccine candidates targeting critical sexually transmitted infections, namely gonorrhea, chlamydia, and syphilis. The core purpose is to provide essential support for Investigational New Drug (IND)-enabling activities. These activities are crucial pre-clinical steps required before any new vaccine can proceed to human clinical trials. A mandatory component of all applications is the inclusion of a comprehensive Product Development Strategy. This strategy must clearly outline the proposed pathway from current research stages through to potential clinical application, ensuring a well-planned approach to vaccine development and accelerating the availability of new preventive tools against these significant public health challenges.
Opportunity ID: 345931
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-AI-23-008 |
| Funding Opportunity Title: | Sexually Transmitted Infections (STI) Cooperative Research Centers (CRC): Vaccine Development (U01 Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.855 — Allergy and Infectious Diseases Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Feb 09, 2023 |
| Last Updated Date: | Feb 09, 2023 |
| Original Closing Date for Applications: | Jun 14, 2023 |
| Current Closing Date for Applications: | Jun 14, 2023 |
| Archive Date: | Jul 20, 2023 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $1,400,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Private institutions of higher education Public housing authorities/Indian housing authorities County governments Others (see text field entitled “Additional Information on Eligibility” for clarification) Small businesses Public and State controlled institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments State governments For profit organizations other than small businesses Special district governments Native American tribal governments (Federally recognized) Native American tribal organizations (other than Federally recognized tribal governments) |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this Funding Opportunity Announcement (FOA) is to advance vaccine candidates for gonorrhea, chlamydia and syphilis by supporting IND-enabling activities. Applications must include a Product Development Strategy. |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-23-008.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 345931 Full Announcement-RFA-AI-23-008 -> RFA-AI-23-008-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-H | Use for due dates on or after January 25, 2023 | PKG00279781 | May 14, 2023 | Jun 14, 2023 | View |
Package 1
Mandatory forms
345931 RR_SF424_5_0-5.0.pdf
345931 PHS398_CoverPageSupplement_5_0-5.0.pdf
345931 RR_OtherProjectInfo_1_4-1.4.pdf
345931 PerformanceSite_4_0-4.0.pdf
345931 RR_KeyPersonExpanded_4_0-4.0.pdf
345931 PHS398_ResearchPlan_5_0-5.0.pdf
345931 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
345931 RR_Budget_3_0-3.0.pdf
345931 RR_SubawardBudget30_3_0-3.0.pdf
345931 PHS398_ModularBudget_1_2-1.2.pdf
345931 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
